About BioStar Capital
BioStar Capital is a value-add investor focused on transformational medical device technologies in cardiovascular and orthopaedic medicine. Combining the insight of experienced investment professionals and medical thought leaders, BioStar Capital identifies proprietary technologies that serve unmet patient needs and fit the acquisition criteria of leading medical device companies. BioStar Capital fills an important gap in medical device development and provides operational skills and clinical expertise in addition to capital, enabling the firm to actively mitigate risk, optimize product development, and secure successful exit.
BioStar Capital Headquarter Location
560 W. Mitchell Street #480
Petoskey, Michigan, 49770,
Latest BioStar Capital News
May 26, 2021
Jeffrey Yau, PhD, VP of Data Science and Engineering at Walmart Global Technology, Joins BioStar Capital as Entrepreneur in Residence 0 PETOSKEY, Mich.–( BUSINESS WIRE )– BioStar Capital , a value-add investment firm focused on transformational medical device technologies that serve unmet patient and physician needs, today announced that Jeffrey Yau, PhD in Economics and VP of Data Science, Data Engineering, and Platform Engineering of Store Associate Tech at Walmart Global Technology, has joined the firm as an entrepreneur in residence (EIR). Dr. Yau was also previously Chief Data Scientist at AllianceBernstein, a global investment management and research firm with almost $700B in assets under management. As an EIR, Dr. Yau will expand BioStar’s expertise within the emerging field of data science and artificial intelligence (AI) in healthcare, as well as…
BioStar Capital Team
8 Team Members
BioStar Capital has 8 team members, including current Chief Financial Officer, Paul A. Scott.